1Parsey KS,Pong A.An open -label,muhicenter study to evaluate Yasmin,a low-dose combination oral contraceptive containing drospironone,a new progestogen.Contraception,2000,61:105 - 111. 被引量：1
2Krattenmacher R.Drospirenone pharmacology and pharmacokinetics of a unique pmgestogen.Contraception 2000 ;62:29 - 38. 被引量：1
3Rubig A.Drospirenone:a new cardiovascular-active progestin with antialdosterone and antiandrogenie properties.Climacteric,2003,6Suppl 3):49 - 54. 被引量：1
4Huber J,Foidart JM,Wuttke W,et at.Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.Eur J Contracept Reprod Health Care,2000,14:25-34. 被引量：1
5Foidart JM,Wuttke W,Bouw GM,et al.A comparative investigation of contraceptive reliability cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.Eur J Contracept Reprod Health Care,2000,5:124-134. 被引量：1
7Palep -singh M,Mook K,Barth J,et al.An observational study of Yasmin in the management of women with polycystic ovary syndrome Journal of Family Planning and Reproductive Health Care,2004,30(3):163 - 165. 被引量：1
8DeLeoV,MorganteG,Piomboni P,et al.Evaluation of effects of an oral contraceptive containing ethinyl estradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogcuic women with polycystic ovary syndrome.Fertil Steril,2007,88 (1):113 - 117. 被引量：1
9Thorneyeroft IH,Gollniek H,Schellsehmidt I,et al.Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.Curls,2004,74:123 -130. 被引量：1
10Van Vloten WA,Van Haselen CW,Van Zuuren EJ,ct al.The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acue and seborrhea.Cutis,2002,69 (Suppl 4):2 - 15. 被引量：1
二级参考文献28
1Parsey KS, Pong A. An open-label, muhicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception, 2000, 61:105- 111. 被引量：1
2Muhn P, Fuhrmann U, Fritzemeier KH, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci, 1995,761:311-335. 被引量：1
3Runnenbaum B, Rabe T. Gynakologische Endokrinologie. Berlin: Springer, 1994:413. 被引量：1
4Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric, 2005,8 suppl 3 : 19-27. 被引量：1
5Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin Repord Med, 2001,19:313-321. 被引量：1
6Borges LE, Andrade RP, Aldrighi JM, et al. Effect of a combination of ethinylestradiol 30 μg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception, 2006,74:446-450. 被引量：1
7Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. J Reprod Med,2002,47 : 14-22. 被引量：1
8Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol, 2004,47:568-575. 被引量：1
9Oelkers WK. Effects of estrogen and progestogens on the reninaldosterone system and blood pressure. Steroids, 1996,61 : 166- 171. 被引量：1
10Eriksson E, Sundblad C, Lisjo P, et al. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology, 1992,17 : 195-204. 被引量：1
